DR. JAD OSMANSKI O.D.
Prescription History 1447402821
Optometrist in North Providence, RI
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JAD OSMANSKI O.D., an active Optometrist specialist practicing in North Providence, RI. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 82 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 46 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other RI PrescribersVs. RI Avg |
|---|---|---|---|
| Latanoprost | 46 | $21.10▼ below RI avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 46 Medicare prescriptions for Latanoprost, about a third of the volume of the typical Rhode Island prescriber of this medication (147). Medicare paid an average of $21.10 per fill, versus $23.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average RI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the RI average for this medication. 89.5 30-Day Fills standardized to 30-day supplies 2,629 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 21 | $9.26▼ below RI avg | ▼ Less than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 21 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about half the volume of the typical Rhode Island prescriber of this medication (41). Medicare paid an average of $9.26 per fill, versus $13.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average RI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the RI average for this medication. 21.7 30-Day Fills standardized to 30-day supplies 277 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $14.70▼ below RI avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 15 Medicare prescriptions for Dorzolamide-Timolol, about a quarter of the volume of the typical Rhode Island prescriber of this medication (70). Medicare paid an average of $14.70 per fill, versus $33.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average RI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the RI average for this medication. 29.5 30-Day Fills standardized to 30-day supplies 885 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. JAD OSMANSKI O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this North Providence, RI practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among RI prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
